APA (7th ed.) Citation

H, F., A, A., F, A., D, D., S, W., E, K., . . . JS, O. (2023). VWF-ADAMTS13 axis dysfunction in children with sickle cell disease treated with hydroxycarbamide vs blood transfusion. Blood advances, 7(22), 6974. https://doi.org/10.1182/bloodadvances.2023010824

Chicago Style (17th ed.) Citation

H, Fogarty, et al. "VWF-ADAMTS13 Axis Dysfunction in Children with Sickle Cell Disease Treated with Hydroxycarbamide Vs Blood Transfusion." Blood Advances 7, no. 22 (2023): 6974. https://doi.org/10.1182/bloodadvances.2023010824.

MLA (9th ed.) Citation

H, Fogarty, et al. "VWF-ADAMTS13 Axis Dysfunction in Children with Sickle Cell Disease Treated with Hydroxycarbamide Vs Blood Transfusion." Blood Advances, vol. 7, no. 22, 2023, p. 6974, https://doi.org/10.1182/bloodadvances.2023010824.